DB
David Baltimore

David Baltimore insider trades: Regulus Therapeutics (RGLS) stock buys and sales

Regulus Therapeutics Last trade Jan 30, 2025 57 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2005
5
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 30, 2025RGLS↑ Buy$21K
May 31, 2017AMGN↓ Sell$570K
Apr 29, 2016AMGN↓ Sell$521K
Mar 2, 2015AMGN↓ Sell$579K
Aug 28, 2013AMGN↓ Sell$502K
Feb 28, 2013AMGN↓ Sell$82K
Dec 10, 2012AMGN↓ Sell$605K
Dec 5, 2008AMGN↓ Sell$1.2M
Nov 18, 2005AMGN↓ Sell$2.5M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About David Baltimore's insider trades

David Baltimore is an insider at Regulus Therapeutics (RGLS). Since Nov 18, 2005, David has reported 1 open-market purchase worth $21K and 8 sales worth $6.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (39 filings), option exercises (9 filings), shares withheld for taxes (7 filings), shares returned to the company (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RGLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.